Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben M Dunn

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of AIDS & Clinical Research|December 24, 2021
Molecular Docking-Based Screening for Novel Inhibitors of the Human Immunodeficiency Virus Type 1 Protease that Effectively Reduce the Viral Replication in Human CellsCarla Mavian, Roxana M Coman, Xinrui Zhang, et al.
Molecular and Biochemical Parasitology|August 4, 2004
Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting manTang Li, Charles A Yowell, Bret B Beyer, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariaeAmrita Madabushi, Sibani Chakraborty, S Zoë Fisher, et al.
Biochemistry|December 21, 2007
The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C proteaseRoxana M Coman, Arthur H Robbins, Marty A Fernandez, et al.
Virology|March 7, 2002
Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 proteaseMaureen M Goodenow, Gregory Bloom, Stephanie L Rose, et al.
Plos One|October 29, 2015
Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium bergheiPeng Liu, Arthur H Robbins, Melissa R Marzahn, et al.
Biochemistry|April 7, 2004
IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solutionTerry B Green, Omjoy Ganesh, Kyle Perry, et al.
Biochemistry|February 9, 2005
Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide librariesBret B Beyer, Jodie V Johnson, Alfred Y Chung, et al.
Journal of Medicinal Chemistry|September 16, 2005
Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulationsKarolina Ersmark, Martin Nervall, Elizabeth Hamelink, et al.
Virology|July 5, 2008
Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug responseSarah K Ho, Roxana M Coman, Joshua C Bunger, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of AIDS & Clinical Research|December 24, 2021
Molecular Docking-Based Screening for Novel Inhibitors of the Human Immunodeficiency Virus Type 1 Protease that Effectively Reduce the Viral Replication in Human CellsCarla Mavian, Roxana M Coman, Xinrui Zhang, et al.
Molecular and Biochemical Parasitology|August 4, 2004
Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting manTang Li, Charles A Yowell, Bret B Beyer, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariaeAmrita Madabushi, Sibani Chakraborty, S Zoë Fisher, et al.
Biochemistry|December 21, 2007
The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C proteaseRoxana M Coman, Arthur H Robbins, Marty A Fernandez, et al.
Virology|March 7, 2002
Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 proteaseMaureen M Goodenow, Gregory Bloom, Stephanie L Rose, et al.
Plos One|October 29, 2015
Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium bergheiPeng Liu, Arthur H Robbins, Melissa R Marzahn, et al.
Biochemistry|April 7, 2004
IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solutionTerry B Green, Omjoy Ganesh, Kyle Perry, et al.
Biochemistry|February 9, 2005
Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide librariesBret B Beyer, Jodie V Johnson, Alfred Y Chung, et al.
Journal of Medicinal Chemistry|September 16, 2005
Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulationsKarolina Ersmark, Martin Nervall, Elizabeth Hamelink, et al.
Virology|July 5, 2008
Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug responseSarah K Ho, Roxana M Coman, Joshua C Bunger, et al.
Pageof 9